← European Medicine Shortage Tracker · all medicines

Bifonazol shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Bifonazol currently has availability issues reported in 2 European registers: Spain, Italy.

Shortage  ATC — · also listed as: BIFONAZOL · BIFONAZOLO · data refreshed 5 October 2026

Key facts

As of 5 October 2026, 2 of the 10 tracked registers list current availability issues for Bifonazol, covering 2 affected product presentations. The longest-running open report was filed in Italy on 2026-02-13 and has now been open for about 8 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-10-15; the earliest is 2026-10-15. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇸 SpainShortage
CANESPIE BIFONAZOL 10 mg/g CREMA, 1 tubo de 20 g
2026-10-042026-10-15El médico prescriptor deberá determinar la posibilidad de otros tratamientos.register ↗
🇮🇹 ItalyShortage
AZOLMEN
2026-02-13—Problemi produttivi
Alternatives: AIFA: an alternative treatment is available (ask your doctor).
register ↗

New register reports per month

2026-02: 12026-03: 02026-04: 02026-05: 02026-06: 02026-07: 02026-08: 02026-09: 02026-10: 12026-022026-10

Full report history (2 register entries)

Every individual register entry for Bifonazol in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇪🇸 ESCANESPIE BIFONAZOL 10 mg/g CREMA, 1 tubo de 20 gShortage2026-10-042026-10-15El médico prescriptor deberá determinar la posibilidad de ot
🇮🇹 ITAZOLMENShortage2026-02-13—Problemi produttivi

Frequently asked

Is Bifonazol currently in shortage in Europe?

Yes. As of 5 October 2026, availability issues are reported in: Spain, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Bifonazol shortage expected to end?

Agency prognoses on file range from 2026-10-15 to 2026-10-15. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Bifonazol?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Bifonazol availability data come from?

Directly from the official medicines-agency registers that list Bifonazol: AEMPS CIMA (Spain), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Bifonazol — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bifonazol/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Bifonazol availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bifonazol/">Bifonazol shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Bifonazol: availability status across 2 European registers — European Medicine Shortage Tracker (MobiDoctor), 5 October 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.